Last reviewed · How we verify

NCT07512570

Feasibility and Preliminary Effects of a Structured Resistance Training Program in Children Aged 10-14 Years

Not yet recruiting NA Last updated 6 April 2026
What this trial tests

NA trial testing Progressive Resistance Training Program in Muscle Architecture in 31 participants. Not yet recruiting.

Timeline
1 September 2026
Primary endpoint
31 December 2027
30 September 2028

Quick facts

Lead sponsorCharles University, Czech Republic
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment31
Start date1 September 2026
Primary completion31 December 2027
Estimated completion30 September 2028
Sites1 location across Czechia

Drugs / interventions tested

Conditions studied

Sponsor

Charles University, Czech Republic

Who can join

Adults 10 to 14, any sex, with Muscle Architecture or Ultrasonic Diagnosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a randomised controlled pilot trial designed to evaluate the feasibility, safety, and preliminary efficacy of a 12-week resistance training intervention in children aged 10-14 years. The study adheres to the CONSORT extension for randomised pilot and feasibility trials and incorporates key elements of the SPIRIT guidelines for clinical trial protocols. The primary purpose of the study is to assess feasibility-related outcomes and to generate effect size estimates to inform the design of a subsequent fully powered randomised controlled trial (RCT).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Muscle Architecture

Currently open trials in the same condition.

Other Charles University, Czech Republic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07512570.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing